FreeStyle Libre 2 is a standout in this market, here’s why:
Unsurpassed 14-day5 accuracy — The FreeStyle Libre 2 system has a combined mean absolute relative difference (MARD), a measurement of performance for CGMs, of 9.3% (9.2% for adults and 9.7% for pediatrics), making it the only iCGM sensor sustaining a high level of accuracy over 14 days.
Minute-by-minute glucose readings — FreeStyle Libre 2 system is the only iCGM system that measures glucose every minute. That’s five times more glucose readings than competitors.
Longest lasting self-applied sensor — At 14 days, the next-gen FreeStyle Libre 2 system is the longest lasting iCGM sensor available.
Fewer false alarms — FreeStyle Libre 2 has one third fewer false alarms for children than Dexcom’s G6.
Accessible and affordable — Compared to other CGMs, FreeStyle Libre 2 will be a third of the cost in the U.S.9 Overall, there are more than 2 million users of FreeStyle Libre family of products worldwide,1 and Abbott has secured partial or full reimbursement for the FreeStyle Libre portfolio in 36 countries including Canada, Japan, the United Kingdom and the U.S.